DrugPatentWatch Database Preview
Profile for Russian Federation Patent: 2494727
US Patent Family Members and Approved Drugs for Russian Federation Patent: 2494727
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | May 29, 2029 | Novartis Pharms Corp | MOXEZA | moxifloxacin hydrochloride |
➤ Sign Up | May 29, 2029 | Novartis Pharms Corp | MOXEZA | moxifloxacin hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |